The term “pemphigus” refers to a group of organ-specific, rare, autoimmune diseases that cause blistering of the skin. Pemphigus foliaceus (PF) is the second most common form of pemphigus. It is ...

This is a rare autoimmune skin disorder that occurs when your immune system starts attacking healthy epidermis cells (the top layer of your skin). Pemphigus can manifest itself as blisters and sores ...

Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin. Pemphigus is ...

The three main types of pemphigus are vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus. a) Pemphigus vulgaris is the most common variety and accounts for 70% of the pemphigus cases. It is ...

PARIS – September 9, 2021 – The Phase 3 PEGASUS trial evaluating rilzabrutinib to treat pemphigus, a rare autoimmune skin condition, did not meet its primary or key secondary endpoints.

A study of patients with pemphigus who were in remission after a rituximab cycle found that administering an additional infusion at month 6, when guided by relapse predictors, significantly improved ...

Please provide your email address to receive an email when new articles are posted on . A trial of adjuvant immunoadsorption for pemphigus diseases was ended early due to adverse events. The time to ...

Desmoglein 1 is the target antigen and probably the initiating immunogen of the autoantibody response in pemphigus foliaceus (PF), a blistering autoimmune skin disease. We previously showed that the ...

Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on mucous membranes like the mouth, eyes, or genitals. It can cause serious complications if it isn’t treated. If you ...

Please provide your email address to receive an email when new articles are posted on . Research shows nearly 20% of patients with pemphigus experience relapse. An additional dose of rituximab in ...

BOSTON--(BUSINESS WIRE)--Syntimmune, Inc., a clinical-stage biotechnology company developing antibody therapeutics targeting FcRn, today announced positive preliminary results from its Phase 1b ...

Pemphigus is the term used to describe a group of autoimmune diseases that cause the skin and mucous membranes to become blistered. The conditions may therefore affect areas of the body such as the ...